• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从孕育到老年的阻塞性肺部疾病:成人和儿童哮喘治疗的差异。

Obstructive lung disease from conception to old age: differences in the treatment of adults and children with asthma.

机构信息

Firestone Institute for Respiratory Health, St. Joseph's Hospital and Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

出版信息

Proc Am Thorac Soc. 2009 Dec;6(8):720-3. doi: 10.1513/pats.200907-059DP.

DOI:10.1513/pats.200907-059DP
PMID:20008883
Abstract

Achieving asthma control is the focus of asthma management. Inhaled corticosteroids are the most effective treatment for asthma in children and adults, with no evidence that the magnitude of benefit differs between adults and school-aged children. Leukotriene inhibitors are more widely used in children than in adults. This may be because provoking stimuli, such as environmental allergens and frequent exercise, are more important asthma triggers in children or because parental concerns about the side effects of treatment with ICS. Inhaled corticosteroid/long-acting inhaled beta(2)-agonist combinations may not be as effective in children as in they are adults in improving asthma control and reducing asthma exacerbations.

摘要

实现哮喘控制是哮喘管理的重点。吸入皮质类固醇是儿童和成人哮喘最有效的治疗方法,没有证据表明其疗效在成人和学龄儿童之间存在差异。白三烯抑制剂在儿童中的应用比在成人中更为广泛。这可能是因为在儿童中,诱发因素(如环境过敏原和频繁运动)更为重要,或者是因为父母对 ICS 治疗的副作用存在担忧。吸入皮质类固醇/长效吸入β2-激动剂联合治疗在改善哮喘控制和减少哮喘恶化方面,在儿童中的效果可能不如在成人中。

相似文献

1
Obstructive lung disease from conception to old age: differences in the treatment of adults and children with asthma.从孕育到老年的阻塞性肺部疾病:成人和儿童哮喘治疗的差异。
Proc Am Thorac Soc. 2009 Dec;6(8):720-3. doi: 10.1513/pats.200907-059DP.
2
Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.白三烯受体拮抗剂和合成抑制剂在哮喘治疗中的疗效
J Allergy Clin Immunol. 2009 Sep;124(3):397-403. doi: 10.1016/j.jaci.2009.05.029. Epub 2009 Jul 16.
3
Evidence-based asthma management.基于证据的哮喘管理。
Respir Care. 2004 Jul;49(7):783-92.
4
Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.维持性长效β受体激动剂与吸入性糖皮质激素对哮喘控制及哮喘急性加重的不同影响。
J Allergy Clin Immunol. 2007 Feb;119(2):344-50. doi: 10.1016/j.jaci.2006.10.043.
5
Inhaled corticosteroids should be the first line of treatment for children with asthma.吸入性皮质类固醇应为哮喘患儿的一线治疗药物。
Paediatr Respir Rev. 2011 Dec;12(4):245-9. doi: 10.1016/j.prrv.2011.05.009. Epub 2011 Sep 17.
6
How do children and their caregivers perceive the benefits of inhaled asthma therapy?儿童及其护理人员如何看待吸入性哮喘治疗的益处?
J Asthma. 2012 Jun;49(5):552-6. doi: 10.3109/02770903.2012.672610. Epub 2012 Apr 10.
7
Managing symptoms and exacerbations in pediatric asthma.小儿哮喘症状及急性加重的管理
Pediatr Pulmonol Suppl. 1997 Sep;15:46-50.
8
Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).孟鲁司特或沙美特罗联合吸入性糖皮质激素治疗成人哮喘:一项随机、双盲对照研究的设计与原理(孟鲁司特作为辅助治疗药物的IMPACT研究)
Respir Med. 2000 Jun;94(6):612-21. doi: 10.1053/rmed.2000.0806.
9
Heterogeneity in response to asthma medications.哮喘药物反应的异质性。
Curr Opin Allergy Clin Immunol. 2007 Apr;7(2):185-9. doi: 10.1097/ACI.0b013e32807fafe7.
10
Inhaled corticosteroids in children: use and effects of early treatment on asthma and lung function. Prevalence of asthma and the impact of severity in early life on later asthma in childhood.儿童吸入性糖皮质激素:早期治疗对哮喘和肺功能的使用及影响。哮喘的患病率以及早期生活中病情严重程度对儿童后期哮喘的影响。
Clin Respir J. 2008 Oct;2(4):247-8. doi: 10.1111/j.1752-699X.2008.00064.x.

引用本文的文献

1
Treatment response according to small airway phenotypes: a real-life observational study.根据小气道表型的治疗反应:一项真实世界观察性研究。
Ther Adv Respir Dis. 2016 Jun;10(3):200-10. doi: 10.1177/1753465816642635. Epub 2016 Apr 8.